CATALOGO DEI PRODOTTI DELLA RICERCA

LATTUADA, Emanuela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.982
EU - Europa 1.765
AS - Asia 1.285
SA - Sud America 221
Continente sconosciuto - Info sul continente non disponibili 69
AF - Africa 39
OC - Oceania 2
Totale 5.363
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.919
RU - Federazione Russa 725
SG - Singapore 523
CN - Cina 380
GB - Regno Unito 305
BR - Brasile 184
IT - Italia 141
VN - Vietnam 123
SE - Svezia 115
DE - Germania 105
IE - Irlanda 96
FR - Francia 88
HK - Hong Kong 87
FI - Finlandia 74
KR - Corea 39
CA - Canada 34
UA - Ucraina 28
BD - Bangladesh 27
JP - Giappone 21
IN - India 20
MX - Messico 18
CZ - Repubblica Ceca 17
AR - Argentina 16
ZA - Sudafrica 16
TR - Turchia 14
PL - Polonia 13
NL - Olanda 12
BE - Belgio 10
NG - Nigeria 10
ES - Italia 8
AT - Austria 7
ID - Indonesia 7
IQ - Iraq 6
SA - Arabia Saudita 6
CL - Cile 5
LT - Lituania 5
PK - Pakistan 5
UZ - Uzbekistan 5
CO - Colombia 4
EG - Egitto 4
AE - Emirati Arabi Uniti 3
EC - Ecuador 3
GR - Grecia 3
MA - Marocco 3
NI - Nicaragua 3
PH - Filippine 3
PY - Paraguay 3
RO - Romania 3
AU - Australia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
GT - Guatemala 2
HR - Croazia 2
IL - Israele 2
JM - Giamaica 2
KZ - Kazakistan 2
NO - Norvegia 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
CD - Congo 1
CH - Svizzera 1
DK - Danimarca 1
EU - Europa 1
GY - Guiana 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
MN - Mongolia 1
PA - Panama 1
SN - Senegal 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 5.296
Salva come PNG Salva come JPEG
Città #
Singapore 292
Moscow 252
Southend 246
Chandler 235
San Jose 175
Ashburn 158
Jacksonville 153
Woodbridge 127
Dublin 95
Dallas 92
Hong Kong 87
Council Bluffs 80
Beijing 75
Ann Arbor 70
New York 51
Los Angeles 46
Verona 45
The Dalles 42
Houston 41
Ho Chi Minh City 38
Lawrence 33
Princeton 33
Jinan 32
Wilmington 29
Munich 28
Shenyang 27
Helsinki 26
Hanoi 24
Nanjing 23
São Paulo 21
Santa Clara 20
Tokyo 19
Buffalo 17
Denver 16
Brno 15
Hebei 15
Orem 15
Montreal 14
Frankfurt am Main 13
Redondo Beach 13
Toronto 13
Turku 13
Warsaw 13
Atlanta 11
London 11
Nanchang 11
Ningbo 11
Bologna 10
Brussels 10
Phoenix 10
San Francisco 10
Seoul 10
Tianjin 10
Abuja 9
Boardman 9
Changsha 9
Johannesburg 9
Amsterdam 8
Haikou 8
Hangzhou 8
Milan 8
Redmond 8
Rio de Janeiro 8
Sindelfingen 8
Zhengzhou 8
Boston 7
Chennai 7
Chicago 7
Jiaxing 7
Lanzhou 7
Brooklyn 6
Clearwater 6
Guangzhou 6
Haiphong 6
Mexico City 6
Norwalk 6
Seattle 6
Stockholm 6
Taizhou 6
Dong Ket 5
Pignone 5
Belo Horizonte 4
Bursa 4
City of London 4
Madrid 4
Manchester 4
Monterrey 4
Mumbai 4
Paris 4
Poplar 4
Querétaro 4
Rome 4
Scandiano 4
Taiyuan 4
Tashkent 4
Thái Nguyên 4
Vicenza 4
Baghdad 3
Barnet 3
Buttapietra 3
Totale 3.248
Salva come PNG Salva come JPEG
Nome #
Acute mediastinitis: a severe complication of transdermal therapy in a patient with ischaemic heart disease. A case report. 200
Pneumatocoele formation during Pneumocystis carinii pneumonia in a man with HIV-1 infection. 193
'High' antiretroviral deintensification strategy and cellular HIV DNA levels 189
Dolutegravir Monotherapy in HIV-Infected Naive Patients With <100,000 Copies/mL HIV RNA Load 187
Relationship between vertebral fractures, bone mineral density, and osteometabolic profile in HIV and Hepatitis B and C-infected patients treated with ART 186
Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life 181
Histoplasmosis in two human immunodeficiency virus-positive immigrants to Italy: clinical features and management in the highly active antiretroviral therapy era. 179
Raltegravir/nevirapine dual therapy at reduced doses as 'maintenance' treatment in virally suppressed HIV-infected patients 177
Is there a role for TNF-alpha in HIV1-associated lipodystrophy? 175
Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient 175
Immunovirological outcome and HIV-1 DNA decay in a small cohort of HIV-1-infected patients deintensificated from Abacavir/Lamivudine/Dolutegravir to Lamivudine plus Dolutegravir 174
Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients 172
Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV-1-infected patients 168
No improvement of lipodystrophy syndrome in an HIV-infected patient. 167
Discontinuation of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy: clinical implications in patients on CD4 T-cell-guided treatment interruption. 164
Monoclonal gammopathy in HIV-Infected patients on stable antiretroviral therapy: disappearance or deep reduction? 164
Recreational substance use and tolerance of efavirenz in HIV-1 infected patients 162
Efficacy and safety of abacavir/lamivudine with raltegravir in treatment-experienced and treatment-naïve patients with HIV-1 infection: an observational, retrospective, multi-centre study 162
Short-Cycle Therapy (5 days on/2 days off) with a lamivudine-dolutegravir two-drug regimen in a cohort of virologically suppressed HIV-infected patients 162
Enanthema as the first clinical manifestation of abacavir hypersensitivity reaction: a case report. 158
Low plasmatic concentration of intensified antiretroviral therapy in a pregnant woman: a case report 158
Efficacy and safety of TAM-sparing antiretroviral regimens in naive HIV-positive patients 150
Darunavir/ritonavir 600/100 mg once daily: it's time for larger non-inferiority randomized trials 147
Dolutegravir monotherapy and body weight gain in antiretroviral naïve patients 143
Increase in visceral adipose tissue in a woman living with HIV after introduction of integrase strand transfer inhibitor 136
Efavirenz dose reduction in HIV-infected patients: a long-term follow-up 135
Efficacy of a reduced dose of darunavir/ritonavir in a cohort of antiretroviral-naive and -experienced HIV-infected patients: a medium-term follow-up 134
Raltegravir plus lamivudine as 'maintenance therapy' in suppressed HIV-1-infected patients in real-life settings 131
mIRTAZAPINE IN AN HIV-INFECTED PATIENT WITH PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 125
Raltegravir: is a 400 mg once-daily dose enough? 124
Prevalence and clinical significance of Ureaplasma urealyticum and Mycoplasma hominis in the lower genital tract of HIV-1-infected women. 123
Short-cycle therapy in {HIV}-infected adults: rilpivirine combination 4 days on/3 days off therapy 109
No influence of nevirapine on vitamin D deficiency in HIV-infected patients 107
Prior Mycobacterium avium complex infection is linked to immunological nonresponsiveness in HIV-infected patients on highly active antiretroviral therapy 85
A precise characterisation of peptide binding stability to HLA-C alleles and correlation with the progression of HIV-1 infection and HIV-1 related neurocognitive impairment 32
A precise characterisation of peptide binding stability to HLA-C alleles and correlation with the progression of HIV-1 infection and HIV-1 related neurocognitive impairment 29
Totale 5.363
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.546
article - articoli 18.234
book - libri 0
conference - conferenze 312
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.092
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022274 0 107 1 25 2 3 3 19 15 11 16 72
2022/2023620 36 85 50 94 62 154 0 39 77 2 10 11
2023/2024287 16 26 30 21 36 48 2 17 3 14 40 34
2024/2025673 37 41 15 97 38 13 37 18 112 46 62 157
2025/20262.361 146 112 119 425 657 161 177 88 215 157 45 59
2026/202772 22 50 0 0 0 0 0 0 0 0 0 0
Totale 5.363